A novel tablet technology that controls disintegration rate through engineered porosity, pore size, and CO2 content. By creating interpenetrating networks of soluble and insoluble components, the tablets deliver tunable dissolution while resisting moisture ingress during storage.
This technology offers a new approach to effervescent tablet design by controlling disintegration through engineered microstructure rather than relying solely on traditional formulation strategies. The core insight is that disintegration rate is governed by the surface area, pore size, porosity, and CO2 content of the tablet, all of which can be tuned through composite processing techniques. By building an interpenetrating network of water-soluble and water-insoluble species, the tablets maintain mechanical strength while moderating moisture ingress, a common challenge for effervescent products that degrade in humid environments. This makes the technology attractive for pharmaceutical, nutraceutical, and consumer product manufacturers seeking more stable, predictable, and customizable effervescent formulations.
Key features:
How it works:
The tablet is constructed as a composite material where the fraction of soluble and insoluble components is precisely controlled. This creates a network that provides mechanical strength while limiting how quickly moisture can penetrate and trigger premature disintegration. The porosity, pore size, and CO2 loading are tuned to achieve a target disintegration rate, giving formulators flexibility to match specific therapeutic or consumer needs.
The concept has been demonstrated in an initial single-experiment validation. A structured development plan is underway, including solubility and compressive strength studies before and after water immersion, aging studies under varied humidity conditions, and evaluation of processing parameters such as tablet pressing schedules. The research team brings over 40 years of carbonate materials expertise, nearly 200 patents, and a track record of spinning out five startups and licensing technology to multiple large corporations, supporting confidence in the path from concept to commercializable, patentable product.
Rutgers University is a comprehensive public research university and New Jersey’s flagship, spanning campuses in New Brunswick–Piscataway, Newark, and Camden. For industry, it offers an integrated clinical and biomedical enterprise through its health system, a statewide extension network for field deployment, and campus-based incubators and pilot-scale facilities that enable prototyping and scale-up. Companies engage through sponsored research, shared core facilities, professional education, and flexible partnership models supported by corporate engagement teams. Research is supported by competitive federal funding from agencies such as NIH, NSF, DOE, and USDA. A dedicated technology transfer office manages IP, licensing, material transfer, and startup formation, providing clear pathways from lab discovery to market.